MicroRNA Marker Combination for Diagnosing Gastric Cancer and Diagnostic Kit
AssigneeMiRXES Lab Pte. Ltd.
InventorRuiyang Zou
Life of this patent
Estimating the term…
Abstract
The present invention relates to the field of molecular biology. Disclosed are a miRNA marker combination and a kit for diagnosing gastric cancer. The miRNA marker combination for diagnosing gastric cancer includes at least four markers selected from: hsa-miR-29c-3p, hsa-miR-424-5p, hsa-miR-103a-3p, hsa-miR-93-5p, hsa-miR-181a-5p, hsa-miR-21-5p, hsa-miR-140-5p, hsa-miR-30e-5p, hsa-miR-142-5p, hsa-miR-126-3p, hsa-miR-183-5p and hsa-miR-340-5p. The marker combination for diagnosing gastric cancer can be used to distinguish blood serum of a patient with gastric cancer from that of a Healthy human. The diagnostic kit of the present invention can diagnosis gastric cancers easily, effectively and non-invasively.
Claims16
A peripheral blood miRNA marker combination for diagnosing gastric cancer, comprising at least five miRNA markers selected from:
- hsa-miR-29c-3p, hsa-miR-424-5p, hsa-miR-103a-3p, hsa-miR-93-5p, hsa-miR-181a-5p, hsa-miR-21-5p, hsa-miR-140-5p, hsa-miR-30e-5p, hsa-miR-142-5p, hsa-miR-126-3p, hsa-miR-183-5p and hsa-miR-340-5p.
Dependencies are inferred from the claim text.